IP Library › Granted Patent US 10,369,257
Granted Patent B2
US 10,369,257 · App. 15/606,004 · Granted Aug 6, 2019

Process for the production of storable implants with an ultrahydrophilic surface

Inventors: Herbert Jennissen (Cologne, DE); Steffen Lüers (Essen, DE); Markus Laub (Essen, DE)
Assignee: Nobel Biocare Services AG
A61L31/088A61F2/0095A61L27/22A61L27/50A61L31/022A61L31/047A61L31/16B05D1/18B65D81/22A61L2300/102A61L2300/252A61L2300/608A61L2400/18A61L2420/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,369,257
App. No.
15/606,004
Granted
Aug 6, 2019
Kind
B2
Abstract

The present invention concerns a process for the production of implants with an ultrahydrophilic surface as well as the implants produced in that way and also processes for the production of loaded, so-called bioactive implant surfaces of metallic or ceramic materials, which are used for implants such as artificial bones, joints, dental implants or also very small implants, for example what are referred to as stents, as well as implants which are further produced in accordance with the processes and which as so-called “delivery devices” allow controlled liberation, for example by way of dissociation, of the bioactive molecules from the implant materials.

Claims (33)

1. A process for the production of a storable implant with an ultrahydrophilic surface, the process comprising the steps of:

providing an implant with an ultrahydrophilic surface, said ultrahydrophilic surface comprising a metal, metallic alloy, or ceramic material with dynamic contact angles from 0° to 10° upon wetting of the surface of the implant with water,

placing the implant into a salt-containing aqueous solution, which is inert in relation to the surface and which encloses the implant on all sides, and

evaporating the salt-containing aqueous solution to dryness under formation of an exsiccation layer that stabilizes and protects the surface of the implant.

2. The process of claim 1 , wherein the salt-containing aqueous solution has a total ion concentration of more than 0.5 mol/l.

3. The process of claim 1 , wherein the salt-containing aqueous solution has a total ion concentration of more than 1 mol/l.

4. The process of claim 1 , wherein the step of evaporation affords a salt layer covering at least the ultrahydrophilic surface of the implant.

5. The process of claim 4 , wherein the salt layer has a layer thickness of 1 to 500 μm.

6. The process of claim 1 , wherein the step of evaporation gives a salt layer enclosing the implant on all sides.

7. The process of claim 1 , comprising the additional step of sterilization of the implant.

8. The process of claim 7 , wherein sterilization of the implant includes sterilization with ionizing radiation.

9. The process of claim 8 , wherein the ionizing radiation is electromagnetic radiation.

10. The process of claim 1 , further comprising the step of immobilising peptides on the ultrahydrophilic surface.

11. The process of claim 10 , wherein the peptides immobilized on the ultrahydrophilic surface are present in a concentration of more than 200 ng/cm 2 .

12. The process of claim 10 , wherein said peptides immobilized on the ultrahydrophilic surface are selected from the group consisting of bone growth factors, transforming growth factor proteins, bone morphogenic proteins, vessel growth factors, VEGF, angiotropin, ubiquitin, and mixtures thereof.

13. The process of claim 1 , wherein the salt-containing aqueous solution comprises a combination of salts.

14. The process of claim 1 , wherein the salt-containing aqueous solution comprises a buffer solution having a pH of 7.2 to 7.6.

15. The process of claim 1 , wherein the salt-containing aqueous solution comprises a salt having a anion comprising SO 4 −− , HPO 4 −− , CH 3 COO − , Cl, Br, NO 4 − , ClO 4 − , CNS − , ClCH 2 COO − , F 3 CCOO − , Cl 2 CHCOO − , Cl 3 CCOO − , or Br 3 CCOO − .

16. The process of claim 1 , wherein the salt-containing aqueous solution comprises a salt having a cation comprising NH 4 + , Rb + , K + , Na + , Cs + , Li + , Mg ++ , Ca ++ , or Ba ++ .

17. The process of claim 1 , wherein the salt-containing aqueous solution comprises a salt having a cation comprising (CH 3 ) 4 N + , (C 2 H5) 4 N + , (C 3 H7) 4 N + , or (C 4 H9) 4 N + .

18. The process of claim 1 , wherein the salt-containing aqueous solution forms a fluid layer of 0.1-0.2 μl/mm 2 on a surface of the implant.

19. The process of claim 1 , wherein the salt-containing aqueous solution comprises non-volatile organic substances.

20. The process of claim 19 , wherein the non-volatile organic substances comprise a polyhydric alcohol.

21. The process of claim 1 , wherein the implant comprises steel.

22. The process of claim 1 , wherein the implant comprises a composite metallic and ceramic material.

23. The process of claim 1 , wherein the implant consists of pure titanium or metallic titanium alloys.

24. The process of claim 1 , wherein the implant is a bone implant or a dental implant.

25. The process of claim 10 , wherein said peptides comprise bone morphogenic proteins.

26. The process of claim 25 , where the bone morphogenic proteins comprise BMP-2 or BMP-7.

27. A process for the production of a storable dental implant with an ultrahydrophilic surface, the process comprising:

providing a dental implant with an ultrahydrophilic surface with dynamic contact angles from 0° to 10° upon wetting of the surface of the implant with water,

placing the dental implant into a salt-containing aqueous solution, which is inert in relation to the surface and which encloses the dental implant on all sides, and

evaporating the salt-containing aqueous solution to dryness under formation of an exsiccation layer that stabilizes and protects the surface of the dental implant.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2019
From: MORPHOPLANT GMBH
To: NOBEL BIOCARE SERVICES AG
Reel/Frame 049475/0567 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2019
From: JENNISSEN, HERBERT P.
To: MORPHOPLANT GMBH
Reel/Frame 049456/0194 →
Priority Claims (1)
DE 10 2007 007 865 · Feb 14, 2007 · national
Continuity (3)
Continuation 14949994 · Nov 24, 2015
Continuation 12527175
Related Publication 20170258969A1 · Sep 14, 2017